يعرض 1 - 20 نتائج من 128 نتيجة بحث عن '"Morales, Serafin"', وقت الاستعلام: 0.54s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    المساهمون: Institut Català de la Salut, Martínez-Jañez N Medical Oncology Department, Ramon y Cajal University Hospital, Hospital Ramón y Cajal, Madrid, Spain. Bellet Ezquerra M Medical Oncology Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Manso Sanchez LM Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain. Henao Carrasco F Oncology, Hospital Universitario Virgen Macarena, Sevilla, Spain. Anton Torres A Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. Morales S Medical Oncology Department, Hospital Arnau de Vilanova - Lleida, Alpicat, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Breast Cancer Research and Treatment;206; https://doi.org/10.1007/s10549-024-07287-w; Martínez-Jañez N, Bellet Ezquerra M, Manso Sanchez LM, Henao Carrasco F, Torres AA, Morales S, et al. First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN. Breast Cancer Res Treat. 2024 Jul;206:317–328.; https://hdl.handle.net/11351/11611; 001194967800001

  3. 3
    Academic Journal

    المساهمون: Institut Català de la Salut, Cescon DW Princess Margaret Cancer Center, University Health Network and University of Toronto, Toronto, Ontario, Canada. Hilton J Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada. Morales Murilo S Lleida Biomedical Research Institute, Lleida, Spain. Layman RM MD Anderson Cancer Center, Houston, Texas. Pluard T Saint Luke’s Cancer Institute, Kansas City, Missouri. Yeo B Olivia Newton-John Cancer Research and Wellness Centre and Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia. Oliveira M Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Clinical Cancer Research;30(2); https://doi.org/10.1158/1078-0432.CCR-23-0133; Cescon DW, Hilton J, Morales Murilo S, Layman RM, Pluard T, Yeo B, et al. A Phase I/II Study of GSK525762 Combined With Fulvestrant in Patients With Hormone Receptor-Positive/HER2-Negative (HR+/HER2−) Advanced or Metastatic Breast Cancer. Clin Cancer Res. 2024 Jan 15;30(2):334–43.; https://hdl.handle.net/11351/10943

  4. 4
  5. 5
    Academic Journal
  6. 6
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
  11. 11
    Academic Journal

    مصطلحات موضوعية: 03.02. Klinikai orvostan

    وصف الملف: text

    Relation: http://publicatio.bibl.u-szeged.hu/23108/1/KahanzetalEJC20211-s2.0-S0959804921004408-main.pdf; Kahán Zsuzsanna; Gil-Gil Miguel; Ruiz-Borrego Manuel; Carrasco Eva; Ciruelos Eva; Muñoz Montserrat; Bermejo Begoña; Margeli Mireia; Antón Antonio; Casas Maribel; Csöszi Tibor; Murillo Laura; Morales Serafín; Calvo Lourdes; Láng István: Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study. EUROPEAN JOURNAL OF CANCER, 156. pp. 70-82. ISSN 0959-8049 (2021)

  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
  17. 17
    Academic Journal

    المساهمون: Institut Català de la Salut, Gil-Gil MJ, Bergamino M Department of Medical Oncology, Institut Català d’Oncologia, IDIBELL, L’Hospitalet, Spain. Bellet M, Saura C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Morales S Department of Medical Oncology, Hospital Arnau de Vilanova, Lleida, Spain. Barnadas A Department of Medical Oncology, Hospital de Sant Pau, Barcelona, Spain. Manso L Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Frontiers in Oncology;11; https://doi.org/10.3389/fonc.2021.645026; Gil-Gil MJ, Bellet M, Bergamino M, Morales S, Barnadas A, Manso L, et al. Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study. Front Oncol. 2021 Jul;11:645026.; https://hdl.handle.net/11351/6949; 000677390600001

  18. 18
  19. 19
    Academic Journal
  20. 20
    Book